Article Text

Download PDFPDF
1041 A multimodal intervention program to improve sexual health and self-perceived quality of life in patients treated for cervical cancer: a randomized prospective study (providence trial)
  1. Blanca Gil-Ibáñez1,
  2. Nuria Carreras-Dieguez2,
  3. Gregorio López1,
  4. Beatriz Sanchez-Hoyo2,
  5. Beatrice Conti-Nuño1,
  6. María De Los Reyes Oliver-Perez1,
  7. Camil Castelo-Branco2,
  8. Tiermes Marina2,
  9. Alvaro Tejerizo1,
  10. Aureli Torné2 and
  11. Berta Diaz-Feijoo2
  1. 1Hospital 12 de Octubre, Madrid, Spain
  2. 2Hospital Clinic de Barcelona, Barcelona, Spain


Introduction/Background Patients with cervical cancer treatment experience a deterioration of sexual function, which negatively affects their quality of life. Prevention of sexual dysfunction is an essential pillar in improving the quality of life of these patients.

The aim of this trial is to assess the impact on sexual function and self-perceived quality of life by including prevention of vaginal dysfunction and patient education compared with standard practice.

Methodology Multi-institutional, national, randomized clinical trial where patients will be randomized 1:1 at diagnosis of cervical cancer to control arm or intervention arm. After treatment, control arm patients will undergo standard follow-up by their referring physician.

The multimodal intervention for patients in the intervention group will include:

  • Application of vaginal estrogens plus hyaluronic-acid cream along with the use of vaginal vibrator

  • Systematic evaluation of the need of systemic hormone replacement therapy and treatment if needed

  • Access to online content about sexuality, nutrition, sports and lifestyle habits

Through four appointments (baseline, 1, 6 and 12 months after treatment), sexual health, vaginal trophism and self-perceived quality of life will be assessed with validated questionnaires such as FSFI, VIH, EORTC QLQ-30 and Cx-24.

122 eligible patients aged 18 years or over with FIGO Stage I-III cervical cancer treated with surgery and/or radiotherapy will be included and randomized.

Results The estimated date for presenting results is May 2026.

Conclusion A systematic multimodal intervention with prevention of vaginal dysfunction of patients after treatment for cervical cancer will improve the sexual function and self-perceived quality of life.

Disclosures The authors of this abstract have no disclosures.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.